Mechanistically, we found that this resulted in the promoters of ERα-target genes being occupied by transcriptional coactivator MED1 in tamoxifen-resistant breast cancer cells rather than the transcriptional corepressors N-CoR and SMRT. The gene discussed is NCOR2; the disease is breast cancer.